NCT03103334View on ClinicalTrials.gov

A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
OTHER

Zeneo® - Methotrexate

0.625 mL of methotrexate solution 40 mg/ML for subcutaneous injection with a prefilled and needle-free delivery system

DRUG

Methotrexate Biodim®

1 mL of methotrexate solution 25 mg/mL for subcutaneous injection with a conventional needle and syringe injection

Sponsors

Lead Sponsor

Crossject
All Listed Sponsors
lead

Crossject

INDUSTRY

NCT03103334 - A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers. | Biotech Hunter | Biotech Hunter